Biocon has announced the appointment of Visionary Leader Mandar Ghatnekar as Chief Technology Officer, reinforcing its commitment to advancing digital innovation and technology-driven growth. Ghatnekar steps into this role after serving as Global Head of IT & Digital Transformation at Biocon Biologics, where he successfully led enterprise-wide digital initiatives and accelerated the adoption of emerging technologies.

With over two decades of exemplary experience in digital transformation and enterprise technology, Ghatnekar brings a strong track record of building scalable technology capabilities and delivering complex transformation programs. His previous leadership roles at Accenture and Johnson & Johnson have equipped him with deep expertise across cloud, data, and life sciences technology.

In his new role, he will focus on driving Biocon’s technology strategy, enhancing digital capabilities, and enabling innovation to improve operational efficiency and patient outcomes. 

CXO TechBOT wishes Mandar Ghatnekar great success in his new role.